Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for viral diarrhea in children
NCT00302640Phase 3Completed
- Sponsor
- Romark Laboratories
- Start
- Feb 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in rotavirus infection, adenovirus infection and norovirus infection comparing Nitazoxanide with Placebo (2 arms). Primary endpoint: Time from first dose to resolution of symptoms. Started Feb 2005; status: completed.
02
Drugs
nitazoxanide
03
Conditions
rotavirus infectionadenovirus infectionnorovirus infection
Beyond the preview
Go deeper on NCT00302640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00302640.